Global burden of metabolic diseases, 1990–2021Huai Zhang, Omar Thaher, Luca Valenti et al.|Metabolism|2024Cited by 294
Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021Xiaodong Zhou, Tamer N. Abdelbaki, Qin‐Fen Chen et al.|EClinicalMedicine|2024Cited by 188
Chylous Ascites: Evaluation and ManagementSaid A. Al‐Busafi, Philip Wong, Peter Ghali et al.|ISRN Hepatology|2014Cited by 171
Antioxidant Therapy in Nonalcoholic SteatohepatitisSaid A. Al‐Busafi, Marc Deschênes, Mamatha Bhat et al.|Hepatitis Research and Treatment|2012Cited by 61
Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021Xiaodong Zhou, Tamer N. Abdelbaki, Qin‐Fen Chen et al.|EClinicalMedicine|2024Cited by 16